1. Home
  2. HNVR vs TLSA Comparison

HNVR vs TLSA Comparison

Compare HNVR & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

HOLD

Current Price

$26.55

Market Cap

153.5M

Sector

Finance

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$0.97

Market Cap

155.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
TLSA
Founded
2008
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
155.3M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
HNVR
TLSA
Price
$26.55
$0.97
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$24.50
N/A
AVG Volume (30 Days)
50.4K
258.6K
Earning Date
04-27-2026
05-04-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
N/A
N/A
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
N/A
P/E Ratio
$106.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.91
$0.87
52 Week High
$27.00
$2.60

Technical Indicators

Market Signals
Indicator
HNVR
TLSA
Relative Strength Index (RSI) 70.55 39.53
Support Level $22.09 N/A
Resistance Level N/A $1.45
Average True Range (ATR) 0.79 0.12
MACD 0.21 -0.02
Stochastic Oscillator 87.36 15.32

Price Performance

Historical Comparison
HNVR
TLSA

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: